Thermo Fisher Scientific, the world leader in serving science, and Celltrio, a leading manufacturer of robotics-based solutions for the life sciences industry, have announced their collaboration to bring a fully automated cell culture system to biotherapeutics customers. The collaboration will integrate the Thermo Scientific Momentum workflow scheduling software with the Celltrio RoboCell cell line automation platform to address the critical unmet market need for high-throughput automated cell line culturing and maintenance...
Eppendorf and the journal Science are now accepting applications for the 2023 Eppendorf & Science Prize for Neurobiology. This annual international research prize of US$25,000 is awarded to young scientists for their outstanding contributions to neurobiological research based on methods of molecular and cell biology. Researchers who are not older than 35 years are invited to apply by June 15, 2023...
TransCure bioServices adds BioVolume 3D imaging to its service offerings, enabling them to deliver even higher quality tumor growth results to customers. With a deeper understanding of how tumors grow and respond to stimuli, researchers can more quickly develop the highly efficacious treatments urgently needed to tackle different cancers. The new service is a world first in 3D imaging, allowing the measurement and visualization of tumor growth in animal models across preclinical research, oncology, and drug development.
As part of a global, multiyear agreement, Thermo Fisher Scientific has announced it is working with AstraZeneca to develop a solid tissue and blood-based companion diagnostic (CDx) test for Tagrisso (osimertinib). The CDx will help identify patients with non-small cell lung cancer (NSCLC) who may be eligible for treatment with Tagrisso by identifying tumors that exhibit epidermal growth factor receptor (EGFR) alterations including exon 21 L858R mutations, exon 19 deletions or T790M mutations...
Dolomite Bio launches new website, with exciting re brand with a new name and focus. The motivation behind the company’s name change to Do Bio reflects their evolution within the microfluidic, biology and life science space. The expertise behind Do Bio’s technology is built on a strong foundation in the field of microfluidics. As the company has grown in recent years, the focus has shifted from purely single cell based applications, to developing and supporting multiple microfluidics based products for life sciences and pharmaceuticals...
Blood samples and urine tests? MRNA or cancer research? Microbe detection in drinking water or PCR tests? Many young women in the UK have virtually no idea what it would be like to work in a laboratory profession as revealed in a survey by laboratory product manufacturer Starlab International. The lack of knowledge of career profiles in science has a severe impact on skills shortage and on many women’s choice of a profession and career opportunities...
Agilent Technologies has announced it is investing approximately $725 million to double manufacturing capacity of therapeutic nucleic acids in response to rapid growth of the $1 billion market and strong demand for the company’s high-quality active pharmaceutical ingredients (API).Therapeutic nucleic acids, also called therapeutic oligonucleotides or oligos, are short DNA and RNA molecules that serve as the API for drugs targeting a growing number of diseases...
Azenta, Inc. has announced that it has acquired Ziath, Ltd. and its subsidiaries ("Ziath"). Based in Cambridge, UK, Ziath is a leading provider of 2D barcode readers for life sciences applications. Founded in 2005, Ziath's innovative 2D barcode readers are a key component of the laboratory automation workflow serving pharmaceutical, biotech and academic customers worldwide...
Automata, a leading robotics and automation company powering life sciences labs, has announced it is partnering with bit.bio, to automate a key aspect of the manufacturing process of their iPSC (induced pluripotent stem cell)-derived human cell products. bit.bio’s precision cellular reprogramming technology opti-ox is ideally suited for automation because it enables unprecedented consistency and scalability for the manufacture of human cells from iPSCs...
Agilent Technologies, Inc. has announced a partnership with Akoya Biosciences, Inc., The Spatial Biology Company®, to develop multiplex-immunohistochemistry diagnostic solutions for tissue analysis and to commercialize workflow solutions for multiplex assays in the clinical research market. Integrating Agilent’s Dako Omnis (autostaining instrument) and Akoya’s PhenoImager® HT (imaging platform) for multiplex chromogenic immunohistochemistry (mIHC) and immunofluorescent (mIF) assays...
Global warming is a challenge for humanity - Sharm el-Sheikh has just reminded us of this again. But in addition to abstract global issues of the UN, small, personal steps can also help. Discussions about sustainability are primarily about energy consumption. Laboratory equipment is no exception. Even the most environmentally friendly and energy efficient ultra-low temperature freezers still require a significant amount of energy to maintain extremely low temperatures of -80 °C 24 hours a day, 7 days a week, for years...
Being committed to continued advances in improving human health, SCHOTT has opened a new facility in Phoenix, Arizona, to expand the development and manufacturing of diagnostics and life science consumables. Launching the first fully integrated microfluidic foundry in the United States validates SCHOTT’s global growth plan and increases production capabilities to help get these products to market faster and more efficiently...
Calibre Scientific is pleased to announce the acquisition of Dynalab Corp. (the “Company”), a Rochester, NY based distributor and manufacturer of laboratory plastics, consumables, equipment, supplies and custom fabricated products serving the scientific, industrial, agricultural, water, pharma and educational markets in the United States. Dynalab marks Calibre Scientific’s debut into the United States distribution market...
Blackford Analysis, one of the leading strategic imaging Artificial Intelligence (AI) platform and solutions provider, has announced its acquisition by Bayer, a global life science company. Spun out from the University of Edinburgh in 2010 and still headquartered in the city, Blackford has a presence in the UK and US focused on providing healthcare providers with tailored tools and services to unlock the value of medical imaging AI, driving efficiencies and improving patient outcomes...
Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, further strengthens its commitment to the greater Loveland, Colorado community with the completion of the first phase of its new research and development hub. The grand opening of the new $10 million office complex will house its growing workforce in the Axis 25 Development at 4510 Byrd Drive near the Northern Colorado Regional Airport...
Science parks can be defined as specialist locations comprising multiple businesses that are all involved in scientific or technological disciplines. Although they can be known by many different names, they all share key elements that combine to result in benefits to all stakeholders – including tenants, investors and funding partners. Dr Ralf Nöcker, Managing Director at ESPG, outlines the key ingredients of a successful science park...
Bruker Corporation has announced the acquisition of ACQUIFER Imaging GmbH, a pioneer in big-data management solutions for bioimaging and high-content microscopy. This acquisition adds high-performance on-premise processing, secure storage and networking technology that complements Bruker’s advanced fluorescence microscopy imaging products, such as light-sheet and super-resolution microscopy products, which generate high information content...
As part of its efforts to support emerging biotechnology companies with addressing key challenges of bringing new therapies to market, Thermo Fisher Scientific has announced it has become a founding sponsor of Momentum Labs in Alachua, Fla. Momentum Labs will serve as a collaborative laboratory and office space for growing biotech businesses in the greater Gainesville region...
PhoreMost Ltd., the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets, and ThinkCyte K.K, a biotechnology company pioneering novel cell analysis and sorting instruments, has announced a strategic research partnership aimed at advancing modern phenotypic drug screening using artificial intelligence (AI)...
Agilent Technologies Inc. has announce that the U.S. Food and Drug Administration (FDA) has approved Agilent Resolution ctDx FIRST as a companion diagnostic (CDx) to identify advanced non-small cell lung cancer (NSCLC) patients with KRAS G12C mutations who may benefit from treatment with KRAZATITM (adagrasib). This is the first liquid biopsy NGS assay approved by the FDA as a CDx for the newly approved KRAZATI in advanced NSCLC and was developed in collaboration with Mirati Therapeutics...
Aptamer Group plc, the developer of novel Optimer® binders to enable innovation in the life sciences industry, announces a selection of new contract wins where Optimer technology is being explored by partners to offer new strategies for therapeutics and potentially offer improved assay sensitivity and selectivity over antibodies. Optimer binders are oligonucleotide-based affinity ligands generated through the in vitro Optimer platform, which can be used as antibody alternatives...
Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, announce the launch of its High Throughput Screening (HTS) capability, as well as the expansion of its state-of-the-art lab and office facilities. Scott Maidment has been appointed as Head of HTS to lead the new service...
Thermo Fisher Scientific, the world leader in serving science, and Celltrio, a leading manufacturer of robotics-based solutions for the life sciences industry, have announced their collaboration to bring a fully automated cell culture system to biotherapeutics customers. The collaboration will integrate the Thermo Scientific Momentum workflow scheduling software with the Celltrio RoboCell cell line automation platform to address the critical unmet market need for high-throughput automated cell line culturing and maintenance...
Eppendorf and the journal Science are now accepting applications for the 2023 Eppendorf & Science Prize for Neurobiology. This annual international research prize of US$25,000 is awarded to young scientists for their outstanding contributions to neurobiological research based on methods of molecular and cell biology. Researchers who are not older than 35 years are invited to apply by June 15, 2023...
TransCure bioServices adds BioVolume 3D imaging to its service offerings, enabling them to deliver even higher quality tumor growth results to customers. With a deeper understanding of how tumors grow and respond to stimuli, researchers can more quickly develop the highly efficacious treatments urgently needed to tackle different cancers. The new service is a world first in 3D imaging, allowing the measurement and visualization of tumor growth in animal models across preclinical research, oncology, and drug development.
As part of a global, multiyear agreement, Thermo Fisher Scientific has announced it is working with AstraZeneca to develop a solid tissue and blood-based companion diagnostic (CDx) test for Tagrisso (osimertinib). The CDx will help identify patients with non-small cell lung cancer (NSCLC) who may be eligible for treatment with Tagrisso by identifying tumors that exhibit epidermal growth factor receptor (EGFR) alterations including exon 21 L858R mutations, exon 19 deletions or T790M mutations...
Dolomite Bio launches new website, with exciting re brand with a new name and focus. The motivation behind the company’s name change to Do Bio reflects their evolution within the microfluidic, biology and life science space. The expertise behind Do Bio’s technology is built on a strong foundation in the field of microfluidics. As the company has grown in recent years, the focus has shifted from purely single cell based applications, to developing and supporting multiple microfluidics based products for life sciences and pharmaceuticals...
Blood samples and urine tests? MRNA or cancer research? Microbe detection in drinking water or PCR tests? Many young women in the UK have virtually no idea what it would be like to work in a laboratory profession as revealed in a survey by laboratory product manufacturer Starlab International. The lack of knowledge of career profiles in science has a severe impact on skills shortage and on many women’s choice of a profession and career opportunities...
Agilent Technologies has announced it is investing approximately $725 million to double manufacturing capacity of therapeutic nucleic acids in response to rapid growth of the $1 billion market and strong demand for the company’s high-quality active pharmaceutical ingredients (API).Therapeutic nucleic acids, also called therapeutic oligonucleotides or oligos, are short DNA and RNA molecules that serve as the API for drugs targeting a growing number of diseases...
Azenta, Inc. has announced that it has acquired Ziath, Ltd. and its subsidiaries ("Ziath"). Based in Cambridge, UK, Ziath is a leading provider of 2D barcode readers for life sciences applications. Founded in 2005, Ziath's innovative 2D barcode readers are a key component of the laboratory automation workflow serving pharmaceutical, biotech and academic customers worldwide...
Automata, a leading robotics and automation company powering life sciences labs, has announced it is partnering with bit.bio, to automate a key aspect of the manufacturing process of their iPSC (induced pluripotent stem cell)-derived human cell products. bit.bio’s precision cellular reprogramming technology opti-ox is ideally suited for automation because it enables unprecedented consistency and scalability for the manufacture of human cells from iPSCs...
Agilent Technologies, Inc. has announced a partnership with Akoya Biosciences, Inc., The Spatial Biology Company®, to develop multiplex-immunohistochemistry diagnostic solutions for tissue analysis and to commercialize workflow solutions for multiplex assays in the clinical research market. Integrating Agilent’s Dako Omnis (autostaining instrument) and Akoya’s PhenoImager® HT (imaging platform) for multiplex chromogenic immunohistochemistry (mIHC) and immunofluorescent (mIF) assays...
Global warming is a challenge for humanity - Sharm el-Sheikh has just reminded us of this again. But in addition to abstract global issues of the UN, small, personal steps can also help. Discussions about sustainability are primarily about energy consumption. Laboratory equipment is no exception. Even the most environmentally friendly and energy efficient ultra-low temperature freezers still require a significant amount of energy to maintain extremely low temperatures of -80 °C 24 hours a day, 7 days a week, for years...
Being committed to continued advances in improving human health, SCHOTT has opened a new facility in Phoenix, Arizona, to expand the development and manufacturing of diagnostics and life science consumables. Launching the first fully integrated microfluidic foundry in the United States validates SCHOTT’s global growth plan and increases production capabilities to help get these products to market faster and more efficiently...
Calibre Scientific is pleased to announce the acquisition of Dynalab Corp. (the “Company”), a Rochester, NY based distributor and manufacturer of laboratory plastics, consumables, equipment, supplies and custom fabricated products serving the scientific, industrial, agricultural, water, pharma and educational markets in the United States. Dynalab marks Calibre Scientific’s debut into the United States distribution market...
Blackford Analysis, one of the leading strategic imaging Artificial Intelligence (AI) platform and solutions provider, has announced its acquisition by Bayer, a global life science company. Spun out from the University of Edinburgh in 2010 and still headquartered in the city, Blackford has a presence in the UK and US focused on providing healthcare providers with tailored tools and services to unlock the value of medical imaging AI, driving efficiencies and improving patient outcomes...
Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, further strengthens its commitment to the greater Loveland, Colorado community with the completion of the first phase of its new research and development hub. The grand opening of the new $10 million office complex will house its growing workforce in the Axis 25 Development at 4510 Byrd Drive near the Northern Colorado Regional Airport...
Science parks can be defined as specialist locations comprising multiple businesses that are all involved in scientific or technological disciplines. Although they can be known by many different names, they all share key elements that combine to result in benefits to all stakeholders – including tenants, investors and funding partners. Dr Ralf Nöcker, Managing Director at ESPG, outlines the key ingredients of a successful science park...
Bruker Corporation has announced the acquisition of ACQUIFER Imaging GmbH, a pioneer in big-data management solutions for bioimaging and high-content microscopy. This acquisition adds high-performance on-premise processing, secure storage and networking technology that complements Bruker’s advanced fluorescence microscopy imaging products, such as light-sheet and super-resolution microscopy products, which generate high information content...
As part of its efforts to support emerging biotechnology companies with addressing key challenges of bringing new therapies to market, Thermo Fisher Scientific has announced it has become a founding sponsor of Momentum Labs in Alachua, Fla. Momentum Labs will serve as a collaborative laboratory and office space for growing biotech businesses in the greater Gainesville region...
PhoreMost Ltd., the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets, and ThinkCyte K.K, a biotechnology company pioneering novel cell analysis and sorting instruments, has announced a strategic research partnership aimed at advancing modern phenotypic drug screening using artificial intelligence (AI)...
Aptamer Group plc, the developer of novel Optimer® binders to enable innovation in the life sciences industry, announces a selection of new contract wins where Optimer technology is being explored by partners to offer new strategies for therapeutics and potentially offer improved assay sensitivity and selectivity over antibodies. Optimer binders are oligonucleotide-based affinity ligands generated through the in vitro Optimer platform, which can be used as antibody alternatives...
Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, announce the launch of its High Throughput Screening (HTS) capability, as well as the expansion of its state-of-the-art lab and office facilities. Scott Maidment has been appointed as Head of HTS to lead the new service...